标志性成果 |
1. 1.科研项目 (1)罗氟司特介导NLRP3炎症小体影响间歇低氧时胰岛β细胞功能和细胞焦亡的研究。山西省科技厅自然基金。起止年月:2022年 03 月 至 2025 年 03月,8万 2. 2.学术论文 [1]Zhihong Liu, Huanhuan Yang, Linping Zhi, Huan Xue, Zhihong Lu, Yanli Zhao, Lijuan Cui, Tao Liu, Shouan Ren, Peifeng He, Yunfeng Liu,Yi Zhang. Sphingosine 1-phosphate stimulates insulin secretion and improves cell survival by blocking voltage-dependent K+ channels in β cells. Frontiers in Pharmacology. 2021, 12; 683674. doi: 10.3389 /fphar.2021.683674. [2] Bo Li, Xiaolu Ren, Hongxia Guo, Yi Guo, Fei Han, Xiaolian Wen, Jing Wu, Xiaomin Li, Yuejun Ren, Xiaoyun Hu, Zhihong Liu. Prognostic role of epidermal growth factor receptor mutation status in patients with de novo lung adenocarcinoma. Translational Cancer Research. 2021;10(3):1549-1558 [3] Xiaolu Ren, Xiaolian Wen, Yue-Jun Ren, Xiang Liu, Jian Wang, Mingyan Hao, Qiang Ma6, Jiwei Ren, Baoli Jin, Xiaoyuan Qiao, Bo Li, Jing Wu, Xiaomin Li, Zhihong Liu. Significance of thyroid transcription factor 1 and Napsin A for prompting the status of EGFR mutations in lung adenocarcinoma patients. Journal of Thoracic Disease; 2022;14(11):4395-4404 3.学术任职 山西省医学会呼吸病学分会委员,山西省医师协会呼吸病学分会常务委员 |